Coinjection with TLR2 Agonist Pam3CSK4 Reduces the Pathology of Leishmanization in Mice

Cutaneous leishmaniasis caused by Leishmania major is an emergent, uncontrolled public health problem and there is no vaccine. A promising prophylactic approach has been immunotherapy with Toll-like receptor (TLR) agonists to enhance parasite-specific immune responses. We have previously reported th...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lu, Hinchman, Meleana, Mendez, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354918/
https://www.ncbi.nlm.nih.gov/pubmed/25738770
http://dx.doi.org/10.1371/journal.pntd.0003546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354918/
https://www.ncbi.nlm.nih.gov/pubmed/25738770
http://dx.doi.org/10.1371/journal.pntd.0003546

Ejemplares similares